In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
about
Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.Therapeutic drug monitoring in methadone maintenance: choosing a matrix.Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment.Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.Treatment of opioid-dependent pregnant women: clinical and research issues.Interindividual variability of methadone response: impact of genetic polymorphism.Management of chronic pain in the elderly: focus on transdermal buprenorphine.Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence.Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.Methadone: a review of drug-drug and pathophysiological interactions.Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features.Buprenorphine in the treatment of opiate dependence.Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.
P2860
Q33807411-6541A422-7EEE-4C8A-8AC0-3358AFF3EB38Q34229211-3802FD3A-9C79-4F9E-9F79-0BC3F7C53FC4Q35906594-923D11C4-58A0-496E-BB09-7CF444015D05Q36311018-C55D5D06-E8A9-4EC9-BE69-994A1E0CA3E1Q36662888-2ECC3B5C-2E4B-4E1F-A7D0-D9B78E5B0A23Q37076673-A8B433B8-45F7-45AE-9888-304314725C13Q37142009-4816AD62-A463-4ECF-B914-418AB508FC0AQ37316802-97815E76-FE3C-4A14-AB5E-09578B3933D7Q37830040-6F8FC5AB-4440-44A1-B688-791AEE5D7EFFQ37845170-A1075E60-18B0-42C9-9FAA-36A8BC3DE651Q37950478-ABC97A6A-F4C0-41A6-BD3B-85B2F2F520CEQ39853590-CD3F18DC-2C89-42DA-9790-AE5E76871634Q42962930-3E2E0C73-A348-4CD1-8386-9E9B943C4D3BQ46565998-BE4EB477-1A79-4799-814B-5F36DB69F9B6
P2860
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@ast
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@en
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@nl
type
label
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@ast
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@en
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@nl
prefLabel
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@ast
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@en
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@nl
P2093
P2860
P1476
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
@en
P2093
P2860
P304
P356
10.1111/J.1472-8206.1998.TB00941.X
P577
1998-01-01T00:00:00Z